-
YM 58483 (BTP2) for SOCE Workflows
2026-08-28
YM 58483 (BTP2) provides a practical way to interrupt sustained store-operated calcium entry in immune-cell activation and radiation-associated fibrosis models. This guide connects calcium-flux measurements with NFAT, IL-2, ORAI2, and TGF-β1 readouts while emphasizing controls and troubleshooting.
-
Diphenyleneiodonium chloride: Redox Assay Workflows
2026-08-28
Diphenyleneiodonium chloride, or DPI, is a versatile probe for separating flavoprotein-dependent oxidative signaling from GPR3-driven cAMP responses. This practical guide translates a citrus canker resistance study into controlled redox, ROS, cell-death, and cAMP workflows, with concentration planning and troubleshooting guidance.
-
RG108: DNA Methyltransferase Inhibitor Guide
2026-08-27
RG108 is a small-molecule DNA methyltransferase inhibitor for experimental epigenetic gene regulation modulation. Its reported 600 nM IC50 in the M.SssI assay supports enzymatic DNMT inhibition, while its non-trapping profile makes it useful for DNA demethylation and tumor suppressor gene reactivation studies.
-
Thermal Shift Assay for Bacterial Sensor Ligands
2026-08-27
The 2025 FEMS Microbiology Reviews article examines how thermal shift assays can reveal ligand recognition by bacterial receptors, solute-binding proteins, and transcriptional regulators. Its main practical contribution is a balanced workflow that combines soluble ligand-binding domains, pH optimization, careful interpretation of thermal shifts, and orthogonal confirmation such as isothermal titration calorimetry.
-
IPR-803: Small-Molecule uPAR Inhibition in Metastasis
2026-08-26
The reference study established compound 4, identified here as IPR-803, as a small-molecule disruptor of the urokinase receptor–urokinase-type plasminogen activator interaction. By combining direct-binding assays, cellular invasion models, pharmacokinetics, and a breast cancer metastasis model, the authors connected molecular PPI inhibition with reduced metastatic burden and defined a starting point for further uPAR inhibitor optimization.
-
Phosbind Acrylamide: Reading Phosphorylation States
2026-08-26
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis by converting phosphate-dependent molecular differences into resolvable SDS-PAGE mobility shifts. This guide focuses on how to interpret those shifts mechanistically, using lessons from MCM8-9 helicase reconstitution to improve assay design and experimental controls.
-
Eicosapentaenoic Acid: Designing Better Assays
2026-08-25
Eicosapentaenoic Acid (EPA) is more than an omega-3 ingredient: it is a concentration-sensitive membrane and lipid-oxidation perturbation tool. This guide connects EPA assay design with emerging lipid-mediated immunology while defining the evidence boundaries for cardiovascular disease research.
-
Meropenem Workflows for Resistance Research
2026-08-25
Build reproducible Meropenem assays for susceptibility testing, time-kill analysis, resistance selection, and Gram-negative infection models. This guide separates evidence-backed product specifications from practical starting conditions and shows how exposure-focused designs can improve translational value.
-
GSK126 EZH2 Inhibitor: Assay Guide
2026-08-24
A scenario-based guide to using GSK126 EZH2 inhibitor (SKU A3446) in viability, proliferation, and cytotoxicity workflows. It connects EZH2 biology with practical dosing, solubility, controls, interpretation, and vendor-selection decisions for reproducible cancer epigenetics research.
-
InstaBlue Protein Stain Solution for tiRNA Workflows
2026-08-24
InstaBlue Protein Stain Solution connects rapid gel visualization with protein-level evaluation of translation-inhibition experiments. Its five-minute, fixation-free workflow supports fast screening, while methanol- and acetic acid-free chemistry helps preserve samples for downstream interpretation and mass spectrometry.
-
Ibotenic Acid: NMDA Receptor Agonist Workflows
2026-08-23
Build better neurotoxicity and circuit-mapping studies with Ibotenic acid, an NMDA receptor agonist that supports time-resolved analysis of glutamatergic signaling. This guide translates product handling, behavioral monitoring, biochemical testing, and tissue readouts into a practical workflow for preclinical neuroscience.
-
Dual HER2–VEGFR2 Targeting in TNBC Metastasis
2026-08-22
The reference study examines whether combining lapatinib with Telatinib can suppress invasion-associated phenotypes and angiogenic activity in the HER2-negative MDA-MB-231 triple-negative breast cancer model. Its main contribution is a preclinical, phenotype-centered evaluation of dual HER2/VEGFR2 pathway targeting, while its findings remain limited to in vitro assays and do not yet establish clinical efficacy or pharmacological synergy.
-
Macrophage EV miR-660 Drives Breast Cancer Metastasis
2026-08-22
The reference study identifies a macrophage-to-tumor communication pathway in which extracellular vesicles transfer miR-660 to breast cancer cells, suppressing KLHL21 and activating IKKβ/NF-κB p65 signaling. Its combined tissue, cell, extracellular-vesicle, and mouse-model evidence links this axis to invasion, migration, and metastatic spread, while also suggesting priorities for mechanistic validation.
-
ACE2, Diminazene Aceturate, and Septic Heart Injury
2026-08-21
The reference study identifies ACE2 downregulation as a component of sepsis-induced cardiomyopathy and links pharmacological ACE2 activation with MasR-Sirt1-mediated mitochondrial biogenesis. Its bidirectional mouse-model design provides a mechanistic framework for interpreting cardiac function, inflammation, oxidative stress, apoptosis, and mitochondrial readouts together, while leaving important questions about pharmacological specificity and clinical translation unresolved.
-
FLAG tag Peptide for Kinesin Assay Workflows
2026-08-20
Build cleaner recombinant kinesin, BicD, and MAP7 workflows with gentle competitive elution, accessible epitope detection, and an enterokinase-compatible design. Practical protocol parameters and troubleshooting guidance help distinguish purification problems from genuine motor-regulation effects.